Which closed-end funds own Amneal Pharmaceuticals LLC?
23 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $28.5M. Security type: loan. Country: United States. CUSIP 03167DAS3 · ISIN US03167DAS36.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EVF Eaton Vance Senior Income Trust | Senior Loans | 0.41% | $597K | 593,689 par | $145M | 13.6% discount | Jun 30, 2026 |
| EFR Eaton Vance Senior Floating-Rate Trust | Senior Loans | 0.40% | $1.9M | 1,935,878 par | $483M | 12.7% discount | Jul 31, 2026 |
| EFT Eaton Vance Floating-Rate Income Trust | Senior Loans | 0.39% | $1.8M | 1,812,375 par | $468M | 10.0% discount | May 31, 2026 |
| BGT BlackRock Floating Rate Income Trust | Senior Loans | 0.34% | $1.4M | 1,430,029 par | $421M | 7.1% discount | Jun 30, 2026 |
| FRA BlackRock Floating Rate Income Strategies Fund | Senior Loans | 0.34% | $1.7M | 1,730,733 par | $515M | 8.6% discount | Jun 30, 2026 |
| XFLT XAI Floating Rate & Alternative Income Trust | Senior Loans | 0.33% | $1.9M | 1,918,150 par | $585M | NAV unavailable | Jun 30, 2026 |
| DSU BlackRock Debt Strategies Fund | Taxable Bonds | 0.27% | $2M | 2,009,952 par | $750M | 6.5% discount | Jun 30, 2026 |
| BLW BlackRock Ltd Duration Income Trust | Taxable Bonds | 0.22% | $1.2M | 1,179,223 par | $532M | 8.5% discount | Jun 30, 2026 |
| JFR Nuveen Floating Rate Income Fund | Senior Loans | 0.17% | $3.7M | 3,675,764 par | $2.2B | 10.5% discount | Jul 31, 2026 |
| CHY Calamos Convertible & High Income Fund | Convertible Securities | 0.13% | $1.9M | 1,939,027 par | $1.5B | 0.8% discount | Jul 31, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | 0.13% | $342K | 340,579 par | $259M | 15.1% discount | Jul 31, 2026 |
| CHI Calamos Convertible Opportunities & Income Fund | Convertible Securities | 0.13% | $1.8M | 1,745,314 par | $1.4B | 4.3% premium | Jul 31, 2026 |
| EVG Eaton Vance Short Duration Diversified Income Fund | Multi-Asset | 0.11% | $191K | 190,000 par | $176M | 5.9% discount | Jul 31, 2026 |
| EVV Eaton Vance Ltd Duration Income Fund | Taxable Bonds | 0.10% | $1.7M | 1,705,878 par | $1.7B | 12.6% discount | Jun 30, 2026 |
| HYT BlackRock Corporate High Yield Fund | High Yield | 0.07% | $1.7M | 1,727,095 par | $2.5B | 10.3% discount | Jun 30, 2026 |
| JQC Nuveen Credit Strategies Income Fund | Taxable Bonds | 0.06% | $748K | 744,380 par | $1.2B | 12.8% discount | Jul 31, 2026 |
| CCD Calamos Dynamic Convertible & Income Fund | Convertible Securities | 0.05% | $472K | 469,742 par | $939M | 7.1% premium | Jul 31, 2026 |
| CSQ Calamos Strategic Total Return Fund | Multi-Asset | 0.05% | $2.3M | 2,290,040 par | $4.9B | 9.0% discount | Jul 31, 2026 |
| CHW Calamos Global Dynamic Income Fund | Taxable Bonds | 0.05% | $393K | 390,751 par | $836M | 11.1% discount | Jul 31, 2026 |
| CGO Calamos Global Total Return Fund | Multi-Asset | 0.04% | $82K | 81,671 par | $197M | 9.7% discount | Jul 31, 2026 |
| BTZ BlackRock Credit Allocation Income Trust | Taxable Bonds | 0.03% | $295K | 293,658 par | $1.2B | 9.7% discount | Jun 30, 2026 |
| NMAI Nuveen Multi-Asset Income Fund | Multi-Asset | 0.02% | $125K | 124,063 par | $691M | NAV unavailable | Jun 30, 2026 |
| ZTR Virtus Total Return Fund | Multi-Asset | 0.01% | $45K | 44,775 par | $533M | 10.1% discount | May 29, 2026 |
23 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Amneal Pharmaceuticals; Amneal Pharmaceuticals 1/26 Cov-Lite TL; Amneal Pharmaceuticals LLC.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Amneal Pharmaceuticals L | debt security | 15 |
Issuer-level search for “AMNEAL PHARMACEUTICALS LLC” → · Compare two funds’ portfolios →